Gallstones
New data from China University illuminate research in gallstones
Published in Drug Law Weekly, February 17th, 2009
According to recent research from Shanghai, People's Republic of China, "In order to investigate whether (-)-Epigallocatechin-3-gallate (EGCG) can reduce the susceptibility to cholesterol gallstone formation in vivo, cholesterol gallstones mouse model was established with lithogenic diet. Compared with the Model group, the administration of EGCG (40 mg kg(-1) d(-1) and 80 mg kg(-1) d(-1), i.g., respectively) significantly reduced the gallstone formation rates and the serum lipid levels, also maintained the body weight at a relatively low level."
"Results of the microarray profiling assay showed the anti-inflammation effect of EGCG underlying affecting the hepatic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2009-02-17)
More Articles from Drug Law Weekly
- AARP
Consumer Advocates Call on Legislature to Support Governor's Ban on Pharmaceutical Gifts to Doctors - Addiction Medicine
'Prescription Drugs: Good Medicine - Bad Behavior;' Science Matters Program Explores the Rise in Prescription Drug Abuse Presented by the California Science Center - Alzheimer Disease
Anavex scales up synthesis of ANAVEX 2-73 for Phase 1 Alzheimer's disease study - Amarin
Amarin to Present at the 11th Annual BIO CEO & Investor Conference - Anti-Defamation League
ADL Praised the Commonwealth of Virginia State Attorney's Office - BDO Consulting Corporate Advisors, LLC
BDO Consulting Corporate Advisors Expands National Practice - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
